Hossam Abdulkhalek: New Insights Into Early Mortality in Palliative Radiotherapy at ESMO 2026
Hossam Abdulkhalek/LinkedIn

Hossam Abdulkhalek: New Insights Into Early Mortality in Palliative Radiotherapy at ESMO 2026

Hossam Abdulkhalek, Divisional Clinical Director of Cancer and Clinical services at Western Health and Social Care Trust, shared a post on LinkedIn:

Real World data is becoming one of the most powerful levers we have to shape the future of cancer care. It reveals what happens beyond clinical trials in routine practice, with real patients, real pressures, and real world constraints. Our study on early mortality in palliative radiotherapy adds an important piece to that picture, helping us refine decision‑making, strengthen prognostic assessment, and ensure that every treatment offered truly aligns with patient benefit.

Grateful to the multidisciplinary colleagues, data teams, and clinical staff who contributed to this work. Your commitment to honest evaluation of practice and continuous improvement is what drives meaningful change for patients across Northern Ireland and beyond.

Looking forward to sharing these insights at ESMO 2026 in Madrid and continuing the conversation on how real world evidence can guide more compassionate, effective, and value‑based cancer care.”

Other articles featuring Hossam Abdulkhalek on OncoDaily.